Péter Ferdinandy, MD, PhD, Dsc, MBA, clinical pharmacologist

Peter Ferdinandy received an MD diploma in 1991 and a PhD degree in 1995. He became a registered clinical pharmacologist in 1999, and obtained DSc degree of the Hungarian Academy of Sciences in 2004. He completed MBA studies in Finance and Quality Management in 2004 at the Budapest University of Technology and Economics. He worked for 2 years at the Department of Pharmacology, University of Alberta, Edmonton, Canada, as a postdoctoral fellow of MRC Canada. He was the head of the Cardiovascular Projects at Biorex Co, (partner of Abbott) a US-Hungarian biotech company, and consulted preclinical and clinical pharmacological projects for several pharmaceutical companies all over the world in the last 15 years. Currently he is a professor of biochemistry and clinical pharmacology, head of the Cardiovascular Research Group, Department of Biochemistry, University of Szeged (for further details, see www.cardiovasc.com). He published over 80 papers in international peer-reviewed journals with close to 400 impact factors and over 1100 independent citations. He is member of the editorial boards of Br J Pharmacol, J Mol Cell Cardiol, and J Pharmacol Toxicol Methods, and the member of the European Committee of the International Society for Heart Research.

Tamás Csont, MD, PhD

Tamás Csont received an MD diploma in 1996 and a PhD degree in 2000 at the University of Szeged, Hungary. He worked for 2.5 years at the Department of Pharmacology, University of Alberta, Edmonton, Canada, as a postdoctoral fellow of the Alberta Heritage Foundation for Medical Research. Currently he is an assistant professor at the Cardiovascular Research Group, Department of Biochemistry, University of Szeged, Hungary (for further details, see www.cardiovasc.com); and holds a "Bolyai János Fellowship" of the Hungarian Academy of Sciences. He published over 30 papers in international peer-reviewed journals with a cumulative impact factor over 100 and independent citations over 300.

Eszter Fodor, MD, clinical pharmacologist, pediatrician

Eszter Fodor received an MD diploma in 1982. She became a registered Pediatrician in 1988, Certified Physician of Health Economy and Management in 1997, and a registered Clinical Pharmacologist in 2003. She worked as a pediatrician for 11 years and as a sport medicine specialist for 2 years. She than became a sales representative of Richter Pharmaceuticals and Sanofi-Chinoin for 4 years. She joined a world-wide CRO in 1997 as a clinical monitor and became a clinical reseach manager of 10 clinical monitors in 2000. She managed more than 40 clinical studies (from phase I to phase IV) from start-up to closure in a wide range of therapeutic indications such as cardiovasular, diabetes, psychiatry, neurology, pediatrics, urology, oncology, gastroenterology, infectology, and dermatology. Her projects successfully passed several FDA, EMEA, MOCK, and other independent audits.

Csaba Csonka received an MD diploma in 1996 and a PhD degree in 2000 at the University of Szeged, Hungary. He received an MSc diploma of Biomedical Engineering in 2002 at the Budapest University of Technology and Economics. He worked for 2 years at the Institute for Molecular Pharmacology, Berlin, Germany as a postdoctoral fellow. Currently he is an assistant professor at the Cardiovascular Research Group, Department of Biochemistry, University of Szeged, Hungary (for further details, see www.cardiovasc.com); and holds a "Bolyai János Fellowship" of the Hungarian Academy of Sciences. He published over 25 papers in international peer-reviewed journals with a cumulative impact factor of 80 and independent citations over 250.

Péter Nagy received an economist diploma from the Management Faculty of Budapest University of Economics and Public Administration in 2003. Earlier he gained a BA diploma of managerial economics from the Kecskémet College. He worked as a trainee for the South-East Central European Sales Center and for the R&D Institute of Knorr-Bremse. Later he was active in the field of corporate credit focused on SMEs financing (Volksbank Hungary, Konzumbank Rt.). In 2003-2004 he worked as a senior investment analyst for a Hungarian financial advisor company. He was involved in company valuations and capital raising projects in the fileld of biotechnology and in the plastic sector (total transactions value of HUF 800 billion). As an independent financial advisor he worked together with KPMG on the financial model of an industrial company in 2004. He is member of the Hungarian Society of Investment Professionals, and the president of the Hungarian Spin-off Companies' Association.